Need a specific person's email?
Browse Bionovis's employee directory (about 338 employees) and reveal verified emails free.
Bionovis's most common email format is First.Last@bionovis.com.br (ex. John.Doe@bionovis.com.br), used for 98% of bionovis.com.br addresses. Bionovis uses 3 email patterns.
| Format | Example | Share of bionovis.com.br |
|---|---|---|
| First.Last@bionovis.com.brMost common | John.Doe@bionovis.com.br | |
| First-Last@bionovis.com.br | John-Doe@bionovis.com.br | |
| First.Middle@bionovis.com.br | John.Michael@bionovis.com.br |
Browse Bionovis's employee directory (about 338 employees) and reveal verified emails free.
Biotechnology ResearchSão Paulo, Brazil201-500 Employees
Bionovis is a 100% Brazilian biotechnology company focused on researching, developing, manufacturing, and commercializing complex biopharmaceuticals of high quality to improve patient outcomes. Situated in the evolving global biopharmaceutical landscape, the company is advancing production of highly complex biological medicines in Brazil. Its development plan includes a pipeline of biosimilars, biobetters, and innovative biopharmaceuticals, supported by capabilities to produce monoclonal antibodies and therapeutic proteins. Its activities are supported by collaborations with global industry leaders and with major national public institutions, aligning its efforts with public health needs. Headquartered in Valinhos, in the São Paulo region, Bionovis is described as a mid-sized enterprise with substantial infrastructure and expertise. In February 2026, the company announced a commitment to the productive development of Pertuzumab, a treatment for HER-2 positive metastatic breast cancer, aimed at serving an estimated 72,000 patients annually.
Most common format
First.Last@bionovis.com.br
Example: John.Doe@bionovis.com.br
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.